Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.655 | Proteogenomic markers for atypical femoral fractures |
Dr. WONG Janus 黃兆謙 |
| 2003.363 | The Effectiveness of Compression Bandaging on Wound Healing and Psychosocial Outcomes in Older People With Venous Ulcers | Prof. WONG Irene Kit Yee |
| 2024.006 | Infective endocarditis database | Prof. WONG Hung Leung Randolph |
| 2015.484 | The accuracy of the Infrascanner as a screening tool for the detection of intracranial hematoma (ICH) in Chinese adult patients with head injury in Hong Kong. |
Mr. WONG Hung Fai 王洪輝 |
| 2018.336 | European active surveillance of renal cell carcinoma study (EASE RCC Study) |
Dr. WONG Hon Ming 黃翰明 |
| 2019.666 | Evaluation on the Effectiveness of 365-days Rehabilitation Service for Stroke Patients in In-patient Extended Care Setting of Hong Kong: a retrospective study |
Ms. WONG Hoi Yan 汪愷恩 |
| 2011.259 | Assessment of near patient environmental contamination levels and contamination of personal stethoscope used for patients I isolation rooms | NA Wong Hoi Wan |
| 2010.513 | Bacterial colonization before and after using non-invasive ventilation: a descriptive study | NA Wong Hoi Wan |
| 2020.596 | Exploring perceived stress and coping style in caregivers of patients with schizophrenia spectrum disorder |
Ms. WONG Hoi Tung 王凱彤 |
| 2022.348 | The Effectiveness of a Pediatric Pharmacist Counselling Service on Pediatric Epilepsy Patients’ Medication Self-Management Efficacy |
Mr. WONG Hoi Chun 黃愷進 |
| 2011.101 | Age, Education and Cognitive Decline - a prospective study of cognitive function in community dwelling Chinese older adults in Hong Kong | Dr Wong Ho Yan Candy |
| 2023.505 | In Vivo Confocal Microscopy (IVCM) Analysis of Corneal Sub-basal nerve plexus (SNP) after Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) in glaucoma patient: A prospective case-control study | Dr. Wong Ho Ming |
| 2023.167 | Audit on secondary prevention of ischemic stroke in a Family Medicine Clinic under the Hospital Authority of Hong Kong | Dr. WONG Hiu Yeung |
| 2021.291 | The setting up of Geriatric Diabetes Programme in a regional hospital of Hong Kong | Dr. WONG Hiu Yan Grace |
| 2009.417 | A prospective cohort of the effectiveness of the Community Psychiatric Team consultation service at halfway houses | Dr. Wong Hiu Mei |
| 2008.048 | The Chinese Version of Structured Clinical Interview for DSM-IV AXIS II Personality Disorders (SCID-II) - Reliability and Validity in Hong Kong Population | Dr. Wong Hiu Mei |
| 2019.383 | Association between cognitive profile and neuropsychiatric symptoms in a randomly recruited community sample of Chinese older adults with subcortical mild vascular neurocognitive disorder and major vascular neurocognitive disorder of mild severity | Dr. WONG Hin Cheong |
| 2012.009 | Volunteer Assisted Support Teleprogram (VAST) for Dementia Caregivers | Prof. Wong Heung-Sang Stephen |
| 2013.227 | Effect of an innovative herbal supplement on oxidative stress after exercise in healthy elderly males: A double-blinded parallel experimental study | Prof. Wong Heung-Sang Stephen |
| 2013.073 | The Impact of Breakfast Glycemic Index on Appetite Control in Primary School Teachers in Hong Kong: A Randomized Cross-over Design | Prof. Wong Heung-Sang Stephen |
| 2014.123 | Breakfast consumption among school teachers in Hong Kong: frequency, nutritional quality and associations with health-compromising behaviors | Prof. Wong Heung-Sang Stephen |
| 2012.140 | Effect of an innovative herbal supplementation on oxidative stress and muscle micro-damage after exercise in healthy males: a double-blinded corssover-designed experimental study | Prof. Wong Heung-Sang Stephen |
| 2014.484 | A social-ecological approach to investigating childhood obesity risk during transition period from primary to secondary schools | Prof Wong Heung Sang Stephen |
| 2016.073 | Effect of Wellness Recovery Action Plan on mental wellbeing among college students who are at risk for depression or anxiety: A randomized controlled trial |
Mr. WONG Henry Cheuk Yin 王卓然 |
| 2015.226 | Prospective study on the prevalence of patent processus vaginalis in asymptomatic paediatric patient who receives laparoscopic surgery | Dr. WONG Hei Yi |
| 2018.300 | Retrospectice review on gastric perforation in neonates in the Chinese population |
Dr. WONG Hei Yi 黃希夷 |
| 2014.022 | A Prospective Study to Characterize the Management and Outcome of Clostridium Difficile Infection in Asian Pacific Countries | Dr. Wong Hei Sunny |
| 2021.156 | Development of a novel nanoparticle-based indicator for rapid point-of-care detection of COVID-19 |
Dr. WONG Hei 黃曦 |
| 2019.070 | Deep learning in clinical parameters to predict hepatic events |
Prof. WONG Grace Lai-Hung 黃麗虹 |
| 2021.091 | Comparative Risk of HCC in CHB Patients Receiving ETV or TDF-based Treatment: IPD Meta-Analysis Protocol |
Dr WONG Grace Lai-Hung 黃麗虹 |
| 2022.656 | A Phase 2a, Randomized, Blinded, Multicenter Study Investigating a Combination of AB-729 and VTP-300 in Virologically-Suppressed Chronic Hepatitis B Participants | Prof. WONG Grace Lai Hung |
| 2021.239 | Retrospective cohort study for early detection of new-onset chronic diseases in recovered COVID-19 patients using population-based datasets | Prof. WONG Grace Lai Hung |
| 2021.443 | Portable liver scans for suspected and confirmed liver diseases |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2019.399 | Role of cryoglobulin in patients with chronic kidney disease | Dr. WONG Grace Lai Hung |
| 2018.554 | A Phase 1b Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Novel Hepatitis B Virus (HBV) Combination Therapies in Chronic Hepatitis B (CHB) Subjects | Prof. WONG Grace Lai Hung |
| 2018.178 | A novel NAFLD-LE model based on liver stiffness measurement and enhanced liver fibrosis (ELF) to predict clinical events in patients with non-alcoholic fatty liver disease |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2013.550 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2013.316 | A randomized controlled trial of a new screening strategy for varices based on liver and spleen stiffness measurement (LSSM) in cirrhotic patients | Dr. WONG Grace Lai Hung |
| 2013.551 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2012.357 | An open-label trial of 48-week peginterferon alfa-2a (PEGASYS) to assess the sustained response of chronic hepatitis B patients with HBeAg seroconversion on nucleot(s)ide analogue therapy | Prof. WONG Grace Lai Hung |
| 2013.105 | A randomized controlled trial on the efficacy of tenofovir disoproxil fumarate (TDF)-switch therapy in chronic hepatitis B patients with incomplete response to entecavir | Dr. WONG Grace Lai Hung |
| 2009.381 | Prevention of recurrent idiopathic gastroduoden ulcer bleeding: a double-blind randomized trial | Dr. WONG Grace Lai Hung |
| 2019.690 | Response after End of Treatment with Antivirals in Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2019.348 | Tenofovir alafenamide (TAF) treatment uptake and impact on ALT normalization in patients with chronic hepatitis B in Hong Kong – real-world cohort study (TAF-RW-HK study) | Dr. WONG Grace Lai Hung |
| 2018.646 | Disease burden of chronic viral hepatitis in Hong Kong – towards eliminating viral hepatitis by year 2030 according to World Health Organization (WHO) targets | Dr. WONG Grace Lai Hung |
| 2018.647 | Gastrointestinal and hepatic adverse events of immune checkpoint inhibitors (ICI) - a territory-wide observational cohort study | Dr. WONG Grace Lai Hung |
| 2020.090 | Serum fibrosis scores based on common laboratory parameters to guide screening strategies for early identification of hepatocellular carcinoma in patients with chronic hepatitis B |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2020.544 | Deep learning of combined clinical data and CT images in patients with chronic viral hepatitis – risk prediction and complication reduction to facilitate eliminating viral hepatitis by year 2030 |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2018.297 | A Phase 2, Randomized, Open-Label, Active-Controlled Study to Evaluate the Safety and Antiviral Activity of GS-9992 Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Chronic Hepatitis B (CHB) Subjects |
Prof. WONG Grace Lai Hung 陳力元教授 |
| 2018.177 | Secular trend of hepatic events in patients with diabetes mellitus - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
Page 33 of 254.